The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients
Open accessAbstract
Coronavirus disease 2019 (COVID-19) is a novel infectious viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Two consecutively negative SARS-CoV-2 viral RNA test ( interval ≥ 24 hours), improved respiratory symptoms and obvious absorption of inflammation in pulmonary imaging are the discharge criteria for COVID-19 patients. The clearance profile of viral RNA in the upper respiratory tract specimens, including nasopharyngeal swab and/or oropharyngeal swabs, is related to innate immune cells such as Natural Killer cells. A total of 168 patients were included for the study. In this cohort, non-severe and severe groups showed significant differences in white blood cells, neutrophils, lymphocytes, basophils and platelets counts, as well as in infection related parameters such as CRP and serum cytokine IL-6. For lymphocyte subsets tests at admission, the severe group displayed significantly lower cell counts than the non-severe group. Higher counts of total T cells, CD4 + T cells, CD8 + T cells, and NK cells in peripheral blood showed a significant correlation with the shorter time taken to obtain the first negative viral RNA test and first positive IgM/ IgG antibody test. The number of B cells was only correlated with time to achieve the first positive IgM/IgG test. The count of NK cells was also correlated with a higher level of IgG antibody (p = 0.025). The lymphocytopenia group had a significantly worse survival rate (p = 0.022) and a longer duration (p = 0.023) of viral shedding than the normal lymphocyte count group. A lower NK cell count correlates the most with the worse survival rate (p<0.001) and a longer duration (p<0.001) of viral shedding. This study suggests the potential value of allo-Natural Killer cell therapy as an universal COVID-19 treatment strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The shared target genes and pathways in corresponding cells were previously shown related to death from COVID-1957–60.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The population of neutrophil, NK cell, T cell, and monocyte increased in deceased severe COVID patients compared to the cured ones, suggesting the important role of these four types of cells in COVID-19-related death57–60 (Fig. 6b).”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662 · cited 1×
“The lymphocytopenia (<1 × 109/L) [3] group had a significantly worse survival rate (log-rank p = 0.”
BackgroundImpaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138554 · Cited by 502 · cited 1×
“NK cells, as a part of innate immune system, play an important role during acute viral infection [5].”
BackgroundPhelan, A. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31034-5 · Cited by 291 · cited 10×
“The strength and duration of IgG after infection is the key point of immunity from SARS-CoV-2 [6].”
InfluentialThe Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?
McKechnie, J. L., & Blish, C. A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.009 · Cited by 222
NAKAYAMA, M., Takeda, K., Kawano, M., Takai, T., Ishii, N., & Ogasawara, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110584108 · Cited by 137 · cited 1×
“NK cells interact with dendritic cells [8] and may play a part in processes of antigen-presentation and adaptive immunity against SARS-CoV-2.”
BackgroundEffect of Natural Compounds on NK Cell Activation
Grudzień, M., & Rapak, A. (2018) · Journal of Immunology Research · doi:10.1155/2018/4868417 · Cited by 128
Ebbo, M., Gérard, L., Carpentier, S., Vely, F., Cypowyj, S., Farnarier, C., Vince, N., Malphettes, M., Fieschi, C., Oksenhendler, É., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.025 · Cited by 96 · cited 1×
“1 × 109/L) [4] group had a significantly worse survival rate (log-rank p < 0.”
BackgroundDendritic Cell Editing by Natural Killer Cells
Ferlazzo, G., & Moretta, L. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014010827 · Cited by 73
Cited by
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Mistry, P., Barmania, F., Mellet, J., Peta, K., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 299
Binder, M. D., Mazereel, V., Stroobants, M., Picker, L. D., Assche, K. V., & Detraux, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.798554 · Cited by 83
“Several therapeutic options for this vulnerable population may exist to reduce the increased mortality rate: the use of medications that target specific inflammatory markers, the use of a cytokine filter targeting multiple different cytokines at a larger scale, natural killer cell-based immunotherapies, and the use of…”
BackgroundNatural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
Vito, C. D., Calcaterra, F., Coianiz, N., Terzoli, S., Voza, A., Mikulak, J., Bella, S. D., & Mavilio, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888248 · Cited by 73
“Moreover, the observation that in SARS-CoV2 infected individuals the count of circulating NK cells is directly correlated with the level of anti-SARS-CoV-2 IgG antibodies suggests that NK cell-DC crosstalk in COVID-19 patients may also affect humoral adaptive immune responses, likely by indirectly promoting the secret…”
BackgroundHammer, Q., Dunst, J., Christ, W., Picarazzi, F., Wendorff, M., Momayyezi, P., Huhn, O., Netskar, H., Maleki, K. T., García, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110503 · Cited by 63
“…or exhaustion is observed in patients with severe disease, suggesting that adequate activity of NK cellsmay be important in disease progression (Bao et al., 2021; Krämer et al., 2021; Liao et al., 2020; Maucourant et al., 2020; Mazzoni et al., 2020; Osman et al., 2020; Sahoo et al., 2021;…”
ASGARD is a single-cell guided pipeline to aid repurposing of drugs
He, B., Xiao, Y., Liang, H., Huang, Q., Du, Y., Li, Y., Garmire, D., Sun, D., & Garmire, L. X. (2023) · Nature Communications · doi:10.1038/s41467-023-36637-3 · Cited by 57
Metadata
- Authors
- Bao, C., Tao, X., Cui, W., Hao, Y., Zheng, S., Yi, B., Pan, T., Young, K. H., & Qian, W.
- Affiliations
- Second Affiliated Hospital of Zhejiang University (CN)
- Second Military Medical University (CN)
- Duke University (US)
- First Affiliated Hospital of Soochow University (CN)
- Corresponding author
- Young, Ken H.
- Qian, Wenbin
- Venue
- Experimental Hematology & Oncology
- Published
- 2021-01-27
- Volume
- 10
- Issue
- 1
- Pages
- 5-5
- ISSN
- 2162-3619 (ISSN-L)
- PMC
- PMC7839286
- OpenAlex
- W3124932440
- Cited by
- 47
- References
- 12
- Citations by year
- 2025: 5 · 2024: 2 · 2023: 7 · 2022: 28 · 2021: 5
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Experimental Hematology and Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The Translation Research Grant of NCRCH (2020ZKZC01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- COVID-19 pandemic, SARS-CoV-2, natural killer cells, viral RNA shedding, viral clearance, antibody response, IgM and IgG antibodies, lymphopenia, mortality, CD4+ T cells, CD8+ T cells, B cells, interleukin-6, C-reactive protein, innate immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients. https://app.cochat.ai/papers/10.1186/s40164-021-00199-1
- The paper
- Bao, C., Tao, X., Cui, W., Hao, Y., Zheng, S., Yi, B., Pan, T., Young, K. H., & Qian, W. (2021). Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-021-00199-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.